Literature DB >> 3366162

Is diurnal variation in absorption of slow-release aminophylline an age-related phenomenon?

A Rodgers1, D N Bateman, K W Woodhouse.   

Abstract

To specifically assess the possible influence of ageing on the changes in theophylline absorption, the plasma concentration-time profiles of sustained-release aminophylline were studied in 8 young and 8 elderly subjects after 9 a.m. and 9 p.m. administration. After 9 p.m. administration, in elderly subjects, maximum plasma theophylline concentrations (Cmax) were decreased, time to maximum concentration (tmax) was increased, and area under plasma concentration-time curve (AUC) was decreased compared to 9 a.m. dosing. This was true for single dose and at steady-state and suggests delayed and diminished absorption at night. No statistically significant changes were seen in the young subjects. This study therefore suggests that time related changes in absorption may be more significant in elderly subjects, possibly due to postural differences after 9 p.m. dosing, and this should be borne in mind when prescribing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366162     DOI: 10.1007/bf00542493

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

Review 1.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

3.  Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

Authors:  A Rodgers; K W Woodhouse; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

4.  Micro-scale method for theophylline in body fluids by reversed-phase, high-pressure liquid chromatography.

Authors:  J J Orcutt; P P Kozak; S A Gillman; L H Cummins
Journal:  Clin Chem       Date:  1977-03       Impact factor: 8.327

5.  Time-dependent absorption of theophylline in man.

Authors:  H Watanabe; S Nakano; K Nagai; N Ogawa
Journal:  J Clin Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.126

6.  Circadian rhythms in theophylline pharmacokinetics and pharmacodynamics in asthmatic children.

Authors:  P H Scott; W G Kramer; M H Smolensky; R Harrist
Journal:  Br J Clin Pract Suppl       Date:  1984

7.  Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.

Authors:  D R Taylor; D Duffin; C D Kinney; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

8.  Temporal variations in trough serum theophylline concentrations at steady state.

Authors:  L J Lesko; D Brousseau; A T Canada; G Eastwood
Journal:  J Pharm Sci       Date:  1980-03       Impact factor: 3.534

9.  Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.

Authors:  J H Jonkman; W J van der Boon; L P Balant; R Schoenmaker; A Holtkamp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.

Authors:  K P Coulthard; D J Birkett; D R Lines; N Grgurinovich; J J Grygiel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  10 in total
  1 in total

Review 1.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.